Amy A. Gelfand
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amy A. Gelfand has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Peter James Goadsby
King Abdullah University of Science and Technology
7 shared publications Peter J. Goadsby
Department of Neurology, Headache Center, University of California, San Francisco, San Francisco CA, USA
3 shared publicationsAmanda C. Reider
School of Medicine, University of California, San Francisco, San Francisco, California
2 shared publications- Heather J. Fullerton
Departments of Neurology and Pediatrics, University of California, San Francisco
2 shared publications Jeffrey M. Gelfand
Department of Neurology, Multiple Sclerosis Center, University of California, San Francisco, San Francisco CA, USA
2 shared publicationsPeter J Goadsby
UCSF Headache Center, Department of Neurology, University of California San Francisco, USA
2 shared publications
Latest Publications
- 9 March 2015
- Published by SAGE Publications in Cephalalgia
- Vol. 35 (14) , 1252-1260
Is migraine a risk factor for pediatric stroke?
Importance: Our understanding of risk factors for childhood stroke is incomplete. In adults, migraine with aura is associated with a two-fold increase in ischemic stroke risk. Objective: In this cohort study we examine the association between migraine and stroke among children in Kaiser Permanente Northern California (KPNC). Design, setting, and participants: Children ages 2–17 years who were members of KPNC for ≥6 months between 1997 and 2007 were included. Migraine cohort members had one or more of: an ICD-9 code for migraine, migraine listed as a significant health problem, or a prescription for a migraine-specific medication. The comparison group was children with no evidence of headache. Main outcome measures: Main outcome measures included stroke incidence rates and incidence rate ratios (IR). Results: Among the 1,566,952 children within KPNC during the study period, 88,164 had migraine, and 1,323,142 had no evidence of headache. Eight migraineurs had a stroke (three (38%) hemorrhagic; five (63%) ischemic). Eighty strokes occurred in children without headache (53 (66%) hemorrhagic; 27 (34%) ischemic). The ischemic stroke incidence rate was 0.9/100,000 person-years in migraineurs vs. 0.4/100,000 person-years in those without headache; IR 2.0 (95% CI 0.8–5.2). A post-hoc analysis of adolescents (12–17 years) showed an increased risk of ischemic stroke among those with migraine; IR 3.4 (95% CI 1.2–9.5). The hemorrhagic stroke incidence rate was 0.5/100,000 person-years in migraineurs and 0.9/100,000 person-years in those without headache; IR 0.6 (95% CI 0.2–2.0). Conclusions: There was no statistically significant increase in hemorrhagic or ischemic stroke risk in pediatric migraineurs in this cohort study. A post-hoc analysis found that ischemic stroke risk was significantly elevated in adolescents with migraine. Future studies should focus on identifying risk factors for ischemic stroke among adolescent migraineurs. Based on adult data, we recommend that migraine aura status should be studied as a possible risk factor for ischemic stroke among adolescent migraineurs.
- 9 March 2015
- Published by SAGE Publications in Cephalalgia
- Vol. 35 (14) , 1252-1260
Is migraine a risk factor for pediatric stroke?
Importance: Our understanding of risk factors for childhood stroke is incomplete. In adults, migraine with aura is associated with a two-fold increase in ischemic stroke risk. Objective: In this cohort study we examine the association between migraine and stroke among children in Kaiser Permanente Northern California (KPNC). Design, setting, and participants: Children ages 2–17 years who were members of KPNC for ≥6 months between 1997 and 2007 were included. Migraine cohort members had one or more of: an ICD-9 code for migraine, migraine listed as a significant health problem, or a prescription for a migraine-specific medication. The comparison group was children with no evidence of headache. Main outcome measures: Main outcome measures included stroke incidence rates and incidence rate ratios (IR). Results: Among the 1,566,952 children within KPNC during the study period, 88,164 had migraine, and 1,323,142 had no evidence of headache. Eight migraineurs had a stroke (three (38%) hemorrhagic; five (63%) ischemic). Eighty strokes occurred in children without headache (53 (66%) hemorrhagic; 27 (34%) ischemic). The ischemic stroke incidence rate was 0.9/100,000 person-years in migraineurs vs. 0.4/100,000 person-years in those without headache; IR 2.0 (95% CI 0.8–5.2). A post-hoc analysis of adolescents (12–17 years) showed an increased risk of ischemic stroke among those with migraine; IR 3.4 (95% CI 1.2–9.5). The hemorrhagic stroke incidence rate was 0.5/100,000 person-years in migraineurs and 0.9/100,000 person-years in those without headache; IR 0.6 (95% CI 0.2–2.0). Conclusions: There was no statistically significant increase in hemorrhagic or ischemic stroke risk in pediatric migraineurs in this cohort study. A post-hoc analysis found that ischemic stroke risk was significantly elevated in adolescents with migraine. Future studies should focus on identifying risk factors for ischemic stroke among adolescent migraineurs. Based on adult data, we recommend that migraine aura status should be studied as a possible risk factor for ischemic stroke among adolescent migraineurs.
- 5 June 2014
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 18 (7) , 1-6
Medication Overuse in Children and Adolescents
Medication overuse is not uncommon among children and adolescents with primary headache disorders. Medication overuse in adults is associated with increased headache frequency and reduced effectiveness of acute and preventive medications. These issues probably exist in children. While withdrawal of overused medications is generally recommended, it may not result in improved headache frequency in all patients. This review summarizes what is known about predicting the response to medication withdrawal. Strategies for managing children and adolescents with medication overuse are also offered.
- 5 June 2014
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 18 (7) , 1-6
Medication Overuse in Children and Adolescents
Medication overuse is not uncommon among children and adolescents with primary headache disorders. Medication overuse in adults is associated with increased headache frequency and reduced effectiveness of acute and preventive medications. These issues probably exist in children. While withdrawal of overused medications is generally recommended, it may not result in improved headache frequency in all patients. This review summarizes what is known about predicting the response to medication withdrawal. Strategies for managing children and adolescents with medication overuse are also offered.
- Open Access
- 22 May 2014
- Published by SAGE Publications in Cephalalgia
- Vol. 35 (1) , 63-72
The relationship between migraine and infant colic: A systematic review and meta-analysis
Infant colic is a common and distressing disorder of early infancy. Its etiology is unknown, making treatment challenging. Several articles have suggested a link to migraine. The objective of this article was to perform a systematic review and, if appropriate, a meta-analysis of the studies on the relationship between infant colic and migraine. Studies were identified by searching PubMed and ScienceDirect and by hand-searching references and conference proceedings. For the primary analysis, studies specifically designed to measure the association between colic and migraine were included. For the secondary analysis, studies that collected data on colic and migraine but were designed for another primary research question were also included. Data were abstracted from the original studies, through communication with study authors, or both. Two authors independently abstracted data. The main outcome measure was the association between infant colic and migraine using both a fixed-effects model and a more conservative random-effects model. Three studies were included in the primary analysis; the odds ratio for the association between migraine and infant colic was 6.5 (4.6–8.9, p < 0.001) for the fixed-effects model and 5.6 (3.3–9.5, p = 0.004) for the random-effects model. In a sensitivity analysis wherein the study with the largest effect size was removed, the odds ratio was 3.6 (95% CI 1.7–7.6, p = 0.001) for both the fixed-effects model and random-effects model. In this meta-analysis, infant colic was associated with increased odds of migraine. If infant colic is a migrainous disorder, this would have important implications for treatment. The main limitation of this meta-analysis was the relatively small number of studies included.
- 22 May 2014
- Published by SAGE Publications in Cephalalgia
- Vol. 35 (1) , 63-72
Open AccessThe relationship between migraine and infant colic: A systematic review and meta-analysis
Infant colic is a common and distressing disorder of early infancy. Its etiology is unknown, making treatment challenging. Several articles have suggested a link to migraine. The objective of this article was to perform a systematic review and, if appropriate, a meta-analysis of the studies on the relationship between infant colic and migraine. Studies were identified by searching PubMed and ScienceDirect and by hand-searching references and conference proceedings. For the primary analysis, studies specifically designed to measure the association between colic and migraine were included. For the secondary analysis, studies that collected data on colic and migraine but were designed for another primary research question were also included. Data were abstracted from the original studies, through communication with study authors, or both. Two authors independently abstracted data. The main outcome measure was the association between infant colic and migraine using both a fixed-effects model and a more conservative random-effects model. Three studies were included in the primary analysis; the odds ratio for the association between migraine and infant colic was 6.5 (4.6–8.9, p < 0.001) for the fixed-effects model and 5.6 (3.3–9.5, p = 0.004) for the random-effects model. In a sensitivity analysis wherein the study with the largest effect size was removed, the odds ratio was 3.6 (95% CI 1.7–7.6, p = 0.001) for both the fixed-effects model and random-effects model. In this meta-analysis, infant colic was associated with increased odds of migraine. If infant colic is a migrainous disorder, this would have important implications for treatment. The main limitation of this meta-analysis was the relatively small number of studies included.
- 1 February 2014
- Published by Elsevier in Pediatric Neurology
- Vol. 50 (2) , 135-139
Outcomes of Greater Occipital Nerve Injections in Pediatric Patients With Chronic Primary Headache Disorders
- 1 February 2014
- Published by Elsevier in Pediatric Neurology
- Vol. 50 (2) , 135-139
Outcomes of Greater Occipital Nerve Injections in Pediatric Patients With Chronic Primary Headache Disorders
- 10 December 2013
- Published by Wolters Kluwer Health in Neurology
- Vol. 81 (24) , e182-e183
Teaching Neuro Images : Infant with glutaric aciduria type 1 presenting with infantile spasms and hypsarrhythmia
A 7-month-old boy with glutaric aciduria type 1 (GA1) presented with 1 week of clustered flexor spasms. Examination revealed mild axial hypotonia without encephalopathy. Video-EEG monitoring revealed hypsarrhythmia and infantile spasms (figure, A). MRI showed acute basal ganglia injury (figure, B). After 3 weeks of prednisolone treatment, 5-month follow-up showed continued resolution of hypsarrhythmia and spasms.
- 10 December 2013
- Published by Wolters Kluwer Health in Neurology
- Vol. 81 (24) , e182-e183
Teaching Neuro Images : Infant with glutaric aciduria type 1 presenting with infantile spasms and hypsarrhythmia
A 7-month-old boy with glutaric aciduria type 1 (GA1) presented with 1 week of clustered flexor spasms. Examination revealed mild axial hypotonia without encephalopathy. Video-EEG monitoring revealed hypsarrhythmia and infantile spasms (figure, A). MRI showed acute basal ganglia injury (figure, B). After 3 weeks of prednisolone treatment, 5-month follow-up showed continued resolution of hypsarrhythmia and spasms.
- 30 July 2013
- Published by Wolters Kluwer Health in Neurology
- Vol. 81 (5) , 431-436
Cranial autonomic symptoms in pediatric migraine are the rule, not the exception
Objective: The presence of cranial autonomic symptoms often leads to a misdiagnosis of “sinus headache” in adult migraineurs, leading to unnecessary treatments and delaying appropriate migraine therapy. In this study, we examined the frequency of cranial autonomic symptoms in pediatric/adolescent patients with migraine. Methods: This cross-sectional study included all pediatric and adolescent patients with migraine evaluated by a single investigator at 4 different sites over the course of the study period. Results: Of 125 pediatric migraineurs, 62% had at least one cranial autonomic symptom based on current International Classification of Headache Disorders, second edition (ICHD-II) criteria, and 70% based on proposed ICHD-III criteria. The majority had more than one cranial autonomic symptom and the symptoms tended to be bilateral. Age, sex, laterality of headache, presence of aura, and whether migraine was episodic vs chronic did not influence the likelihood of having cranial autonomic symptoms. Conclusions: In pediatric/adolescent migraine, the presence of cranial autonomic symptoms appears to be the rule rather than the exception. Clinicians should be careful to consider migraine when evaluating a child with headache and associated ocular or nasal symptoms so as to avoid giving a misdiagnosis of sinus headache.
- 30 July 2013
- Published by Wolters Kluwer Health in Neurology
- Vol. 81 (5) , 431-436
Cranial autonomic symptoms in pediatric migraine are the rule, not the exception
Objective: The presence of cranial autonomic symptoms often leads to a misdiagnosis of “sinus headache” in adult migraineurs, leading to unnecessary treatments and delaying appropriate migraine therapy. In this study, we examined the frequency of cranial autonomic symptoms in pediatric/adolescent patients with migraine. Methods: This cross-sectional study included all pediatric and adolescent patients with migraine evaluated by a single investigator at 4 different sites over the course of the study period. Results: Of 125 pediatric migraineurs, 62% had at least one cranial autonomic symptom based on current International Classification of Headache Disorders, second edition (ICHD-II) criteria, and 70% based on proposed ICHD-III criteria. The majority had more than one cranial autonomic symptom and the symptoms tended to be bilateral. Age, sex, laterality of headache, presence of aura, and whether migraine was episodic vs chronic did not influence the likelihood of having cranial autonomic symptoms. Conclusions: In pediatric/adolescent migraine, the presence of cranial autonomic symptoms appears to be the rule rather than the exception. Clinicians should be careful to consider migraine when evaluating a child with headache and associated ocular or nasal symptoms so as to avoid giving a misdiagnosis of sinus headache.
- 1 June 2013
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 26 (3) , 262-268
Migraine and childhood periodic syndromes in children and adolescents
This review covers recent advances in our understanding of migraine and childhood periodic syndromes in children and adolescents, as well as the treatment of these disorders. The childhood periodic syndromes include benign paroxysmal torticollis, benign paroxysmal vertigo, abdominal migraine, and cyclic vomiting syndrome. Recent research suggests infant colic may also fit into this category. Migraine headache is common in children and adolescents, and chronic migraine effects 0.8-1.8% of adolescents and 0.6% of children. Two triptans are now FDA-approved for the acute treatment of migraine in pediatric patients. For preventive therapy, a number of medications have been studied and a major national trial is ongoing. Childhood periodic syndromes are thought to be early life expressions of those genes that later in life are expressed as migraine headache. Future research into mechanisms of identifying children with these disorders prior to extensive and often invasive testing would be of benefit to these families and children. Migraine-specific therapies are now approved for the acute treatment of migraine in pediatric patients. Preventive migraine therapy is indicated in appropriate patients, although which medications are most effective in children is an area of active research.
- 1 June 2013
- Published by Wolters Kluwer Health in Current Opinion in Neurology
- Vol. 26 (3) , 262-268
Migraine and childhood periodic syndromes in children and adolescents
This review covers recent advances in our understanding of migraine and childhood periodic syndromes in children and adolescents, as well as the treatment of these disorders. The childhood periodic syndromes include benign paroxysmal torticollis, benign paroxysmal vertigo, abdominal migraine, and cyclic vomiting syndrome. Recent research suggests infant colic may also fit into this category. Migraine headache is common in children and adolescents, and chronic migraine effects 0.8-1.8% of adolescents and 0.6% of children. Two triptans are now FDA-approved for the acute treatment of migraine in pediatric patients. For preventive therapy, a number of medications have been studied and a major national trial is ongoing. Childhood periodic syndromes are thought to be early life expressions of those genes that later in life are expressed as migraine headache. Future research into mechanisms of identifying children with these disorders prior to extensive and often invasive testing would be of benefit to these families and children. Migraine-specific therapies are now approved for the acute treatment of migraine in pediatric patients. Preventive migraine therapy is indicated in appropriate patients, although which medications are most effective in children is an area of active research.
- 1 April 2013
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 2 (2) , 73-79
Migraine and multiple sclerosis: Epidemiology and approach to treatment
- 1 April 2013
- Published by Elsevier in Multiple Sclerosis and Related Disorders
- Vol. 2 (2) , 73-79
Migraine and multiple sclerosis: Epidemiology and approach to treatment
- 1 January 2013
- Published by Elsevier in Pediatric Neurology
- Vol. 48 (1) , 36-41
Genetic Risk Factors for Perinatal Arterial Ischemic Stroke
- 1 January 2013
- Published by Elsevier in Pediatric Neurology
- Vol. 48 (1) , 36-41
Genetic Risk Factors for Perinatal Arterial Ischemic Stroke
- 1 October 2012
- Published by Elsevier in Pediatric Neurology
- Vol. 47 (4) , 233-241
Treatment of Pediatric Migraine in the Emergency Room
- 1 October 2012
- Published by Elsevier in Pediatric Neurology
- Vol. 47 (4) , 233-241
Treatment of Pediatric Migraine in the Emergency Room